Canmax Technologies Co

Canmax Technologies Co EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of Canmax Technologies Co (300390.SZ) as of Oct 22, 2026 is 146.45. In the previous year, EV/EBIT (Enterprise Value to EBIT) was 39.28 — a change of 272.80% (higher).

EV/EBIT

146.45

YoY

272.80%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of Canmax Technologies Co is 2025 146.45 . EV/EBIT (Enterprise Value to EBIT) of Canmax Technologies Co was 2024 39.28 . It decreases by 272.80% higher compared to the previous year.

The Canmax Technologies Co EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBIT
Date
EV/EBIT
Jan 1, 2019
646.63 CNY
Jan 1, 2020
147.26 CNY
Jan 1, 2021
33.04 CNY
Jan 1, 2022
4.68 CNY
Jan 1, 2023
19.52 CNY
Jan 1, 2024
39.28 CNY
Jan 1, 2025
146.45 CNY
Jan 1, 2026 (e)
4.70 CNY
The Canmax Technologies Co EV/EBIT history
YEAREV/EBITYoY
est4.70-96.79%
146.45+272.80%
39.28+101.21%
19.52+316.93%
4.68-85.83%
33.04-77.56%
147.26-77.23%
646.63-27.27%
889.06-19.41%
1,103.24-51.95%
2,295.89+164.62%
867.63-15.81%
1,030.53—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Canmax Technologies Co Valuation

Details

Historical Valuation Multiples

ⓘ

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Canmax Technologies Co's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Canmax Technologies Co's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Canmax Technologies Co's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Canmax Technologies Co grows earnings faster than its peers.

Canmax Technologies Co Stock analysis

What does Canmax Technologies Co do? Canmax Technologies Co., Ltd. generates revenue through three core business segments. The Anti-static Ultra-clean Product segment sells human body protection systems, process protection systems, and environmental protection systems for cleanroom and ESD control. The Medical Device Product segment offers self-destruction syringes, safety syringes, and high pressure syringes. The Lithium Battery Material Product segment focuses on battery-grade lithium hydroxide, covering R&D, production, and sales. Domestic and overseas markets are the primary sales channels for all product lines. The company's customers include manufacturers requiring cleanroom solutions, healthcare providers needing medical devices, and battery producers seeking lithium hydroxide. These segments serve distinct industries: cleanroom and ESD control for electronics manufacturing, medical devices for healthcare, and battery materials for energy storage. The firm's product portfolio targets specific industrial needs within these sectors. Revenue streams are derived from the sale of anti-static ultra-clean products, medical devices, and lithium hydroxide. The Anti-static Ultra-clean Product segment supports electronics manufacturing with specialized systems, while the Medical Device Product segment caters to healthcare safety standards. The Lithium Battery Material Product segment meets demand for battery-grade lithium hydroxide in the growing energy storage market. Canmax Technologies Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Canmax Technologies Co stock

EV/EBIT (Enterprise Value to EBIT) of Canmax Technologies Co is 146.45 in 2025.

EV/EBIT (Enterprise Value to EBIT) of Canmax Technologies Co changed from 39.28 to 146.45, representing a 272.80% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/EBIT (Enterprise Value to EBIT) Canmax Technologies Co since 2006 – with annual values, charts, and detailed analysis.

The EV/EBIT ratio measures a company's enterprise value relative to its operating earnings. It accounts for debt, making it useful for comparing companies with different capital structures.

EV/EBIT = Enterprise Value / Earnings Before Interest and Taxes

To evaluate EV/EBIT (Enterprise Value to EBIT)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBIT (Enterprise Value to EBIT).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBIT (Enterprise Value to EBIT)'s Canmax Technologies Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Canmax Technologies Co

All Key Metrics — Canmax Technologies Co